Atai Life Sciences EPS - Earnings per Share 2020-2024 | ATAI
Atai Life Sciences eps - earnings per share from 2020 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Atai Life Sciences Annual EPS |
2023 |
$-0.25 |
2022 |
$-0.98 |
2021 |
$-1.21 |
2020 |
$-1.83 |
2019 |
$-0.16 |
Atai Life Sciences Quarterly EPS |
2024-06-30 |
$-0.36 |
2024-03-31 |
$-0.17 |
2023-12-31 |
$-0.08 |
2023-09-30 |
$0.25 |
2023-06-30 |
$-0.21 |
2023-03-31 |
$-0.21 |
2022-12-31 |
$-0.28 |
2022-09-30 |
$-0.22 |
2022-06-30 |
$-0.24 |
2022-03-31 |
$-0.24 |
2021-12-31 |
$-0.64 |
2021-09-30 |
$-0.21 |
2021-06-30 |
$-0.37 |
2021-03-31 |
$0.01 |
2020-12-31 |
$-0.89 |
2020-09-30 |
$-0.92 |
2020-06-30 |
$-0.18 |
2020-03-31 |
$0.16 |
2019-12-31 |
$0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.198B |
$0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|